Taken together, upregulating VEGFR3 signaling is a potential therapeutic strategy to repair lymphangiogenesis in obesity and adipose-targeted administration of VEGFR3 ligands might be more beneficial than systemic approaches. This evidence concerns the gene FLT4 and Obesity.